Citation： 程若川. 2015年版较2009年版ATA指南对甲状腺乳头状癌的手术治疗变化及解读. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(10): 1166-1168. doi: 10.7507/1007-9424.20160299 Copy
| 1. | Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA, 2015, 313(9):926-935. |
| 2. | Rosário PW, Purisch S. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules. Arq Bras Endocrinol Metabol, 2010, 54(1):52-55. |
| 3. | Kwak JY, Koo H, YoukJH, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology, 2010, 254(1):292-300. |
| 4. | Leboulleux S, GirardE, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9):3590-3594. |
| 5. | Frasoldati A, Valcavi R. Challenges in neck ultrasonography:lymphadenopathy and parathyroid glands. Endocr Pract, 2004, 10(3):261-268. |
| 6. | Grant CS, Hay I, Gough ID, et al. Local recurrence in papillary thyroid carcinoma:is extent of surgical resection important? Surgery, 1988, 104(6):954-962. |
| 7. | Matsuzu K, SuginoK, Masudo K, et al. Thyroid lobectomy for papillary thyroid cancer:long-term follow-up study of 1088 cases. World J Surg, 2014, 38(1):68-79. |
| 8. | Barney BM, Hitchcock YJ, SharmaP, et al. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or totalthyroidectomy for differentiated thyroid cancer. Head Neck, 2011, 33(5):645-649. |
| 9. | Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival:an analysis of 61775 patients. Ann Surg, 2014, 260(4):601-605. |
| 10. | Hay ID, ThompsonGB, GrantCS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999):temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg, 2002, 26(8):879-885. |
| 11. | American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1,Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11):1167-1214. |
| 12. | Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1):1-133. |
| 13. | Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg, 2012, 255(4):777-783. |
| 14. | Popadich A, Levin O, Lee JC, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery, 2011, 150(6):1048-1057. |
| 15. | Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11):1144-1152. |
| 16. | Wang TS, Evans DB, Fareau GG, et al. Effect of Prophylactic Central Compartment Neck Dissection on Serum Thyroglobulin and Recommendations for Adjuvant Radioactive Iodine in Patients with Differentiated Thyroid Cancer. Ann Surg Oncol. 2012, 19(13):4217-4222. |
| 17. | Hartl DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg, 2013, 37(8):1951-1958. |
| 18. | Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm:implications for radioiodine treatment. J Clin Endocrinol Metab, 2009, 94(4):1162-1167. |
| 19. | Laird AM, Gauger PG, Miller BS, et al. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. World J Surg, 2012, 36(6):1268-1273. |
| 20. | Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid, 2011, 21(8):845-853. |
| 21. | Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab, 2012, 97(8):2706-2713. |
| 22. | Uchida H, Imai T, Kikumori T, et al. Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg today, 2013, 43(8):848-853. |
| 23. | Lorente-Poch L, Sancho JJ, Ruiz S, et al. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg, 2015, 102(4):359-367. |
| 24. | Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline:improving voice outcomes after thyroid surgery. Head Neck Surg, 2013, 148(6):S1-S37. |
| 25. | Riemann B, Kramer JA, Schmid KW, et al. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 2010, 49(3):79-84. |
| 26. | Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma:a study of 34 patients. Mod Pathol, 2000, 13(2):123-130. |
| 27. | 高明. 甲状腺结节和分化型甲状腺癌诊治指南. 中国肿瘤临床, 2012, 33(17):1249-1272. |
| 28. | 中国抗癌协会甲状腺癌专业委员会(CATO). 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版). 中国肿瘤临床, 2016, 43(10):405-411. |
| 29. | 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版). 中国实用外科杂志, 2013, 33(6):470-474. |
| 30. | 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识. 中国实用外科杂志, 2015, 35(7):731-736. |
- 1. Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA, 2015, 313(9):926-935.
- 2. Rosário PW, Purisch S. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules. Arq Bras Endocrinol Metabol, 2010, 54(1):52-55.
- 3. Kwak JY, Koo H, YoukJH, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology, 2010, 254(1):292-300.
- 4. Leboulleux S, GirardE, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9):3590-3594.
- 5. Frasoldati A, Valcavi R. Challenges in neck ultrasonography:lymphadenopathy and parathyroid glands. Endocr Pract, 2004, 10(3):261-268.
- 6. Grant CS, Hay I, Gough ID, et al. Local recurrence in papillary thyroid carcinoma:is extent of surgical resection important? Surgery, 1988, 104(6):954-962.
- 7. Matsuzu K, SuginoK, Masudo K, et al. Thyroid lobectomy for papillary thyroid cancer:long-term follow-up study of 1088 cases. World J Surg, 2014, 38(1):68-79.
- 8. Barney BM, Hitchcock YJ, SharmaP, et al. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or totalthyroidectomy for differentiated thyroid cancer. Head Neck, 2011, 33(5):645-649.
- 9. Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival:an analysis of 61775 patients. Ann Surg, 2014, 260(4):601-605.
- 10. Hay ID, ThompsonGB, GrantCS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999):temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg, 2002, 26(8):879-885.
- 11. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1,Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11):1167-1214.
- 12. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1):1-133.
- 13. Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg, 2012, 255(4):777-783.
- 14. Popadich A, Levin O, Lee JC, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery, 2011, 150(6):1048-1057.
- 15. Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11):1144-1152.
- 16. Wang TS, Evans DB, Fareau GG, et al. Effect of Prophylactic Central Compartment Neck Dissection on Serum Thyroglobulin and Recommendations for Adjuvant Radioactive Iodine in Patients with Differentiated Thyroid Cancer. Ann Surg Oncol. 2012, 19(13):4217-4222.
- 17. Hartl DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg, 2013, 37(8):1951-1958.
- 18. Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm:implications for radioiodine treatment. J Clin Endocrinol Metab, 2009, 94(4):1162-1167.
- 19. Laird AM, Gauger PG, Miller BS, et al. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. World J Surg, 2012, 36(6):1268-1273.
- 20. Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid, 2011, 21(8):845-853.
- 21. Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab, 2012, 97(8):2706-2713.
- 22. Uchida H, Imai T, Kikumori T, et al. Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg today, 2013, 43(8):848-853.
- 23. Lorente-Poch L, Sancho JJ, Ruiz S, et al. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg, 2015, 102(4):359-367.
- 24. Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline:improving voice outcomes after thyroid surgery. Head Neck Surg, 2013, 148(6):S1-S37.
- 25. Riemann B, Kramer JA, Schmid KW, et al. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 2010, 49(3):79-84.
- 26. Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma:a study of 34 patients. Mod Pathol, 2000, 13(2):123-130.
- 27. 高明. 甲状腺结节和分化型甲状腺癌诊治指南. 中国肿瘤临床, 2012, 33(17):1249-1272.
- 28. 中国抗癌协会甲状腺癌专业委员会(CATO). 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版). 中国肿瘤临床, 2016, 43(10):405-411.
- 29. 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版). 中国实用外科杂志, 2013, 33(6):470-474.
- 30. 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识. 中国实用外科杂志, 2015, 35(7):731-736.
-
Previous Article
甲状腺微小乳头状癌淋巴结转移特点及处理策略 -
Next Article
甲状腺微小乳头状癌的细针穿刺及手术时机的把握